文献速递脑血管病

阵发性心房颤动进展为持续性心房颤动与不良事件增加相关

Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events.
PubMed 文献 · Stroke · 2018-01-01

Fushimi AF Registry前瞻性社区调查纳入4045例心房颤动患者,基线阵发性1974例、持续性2071例。中位随访1105天期间252例阵发性患者进展为持续性,进展期缺血性卒中或系统性栓塞及心衰住院风险显著升高,进展后风险与持续性房颤相当。

要点

  • 阵发性房颤进展为持续性房颤的发生率为4.22/100人年。
  • 进展期缺血性卒中或系统性栓塞风险较未进展阵发性房颤升高(校正HR 4.10)。
  • 进展期心衰住院风险较未进展阵发性房颤升高(校正HR 2.70)。

核心结论

  • 在日本房颤患者中,阵发性房颤进展为持续性房颤的进展期与临床不良事件风险增加相关。
  • 不良事件风险在进展期短暂升高,进展后降至与持续性房颤相当的水平。

研究设计与样本

  • Fushimi AF Registry是一项在京都伏见区开展的社区为基础的前瞻性调查。
  • 分析纳入4045例房颤患者,基线阵发性房颤1974例(48.8%),持续性(持久性或永久性)房颤2071例(51.2%)。

主要发现

  • 中位随访1105天期间,252例阵发性房颤患者发生进展,发生率为4.22/100人年。
  • 进展期缺血性卒中或系统性栓塞风险较未进展阵发性房颤升高(校正HR 4.10,95%CI 1.95-8.24,P<0.001),较持续性房颤亦升高(校正HR 2.20,95%CI 1.11-4.00,P=0.025)。
  • 进展后缺血性卒中或系统性栓塞风险与持续性房颤相当(校正HR 1.54,95%CI 0.78-2.75,P=0.201)。
  • 进展期心衰住院风险较未进展阵发性房颤升高(校正HR 2.70,95%CI 1.55-4.52,P<0.001),较持续性房颤亦升高(校正HR 1.81,95%CI 1.08-2.88,P=0.026)。

关键数值与推荐

  • 阵发性房颤进展定义为从阵发性进展为持续性(持久性或永久性)房颤。
  • 进展期缺血性卒中或系统性栓塞风险比较:vs 未进展阵发性房颤校正HR 4.10(95%CI 1.95-8.24,P<0.001);vs 持续性房颤校正HR 2.20(95%CI 1.11-4.00,P=0.025)。
  • 进展后缺血性卒中或系统性栓塞风险 vs 持续性房颤校正HR 1.54(95%CI 0.78-2.75,P=0.201)。
  • 进展期心衰住院风险比较:vs 未进展阵发性房颤校正HR 2.70(95%CI 1.55-4.52,P<0.001);vs 持续性房颤校正HR 1.81(95%CI 1.08-2.88,P=0.026)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Atrial fibrillation (AF) is a common arrhythmic disorder among the elderly and sometimes progresses from paroxysmal to sustained (persistent or permanent) types. Clinical outcomes of patients with progression of AF were unknown. This study assessed the characteristics of patients with AF progression and the impact of AF progression on various clinical events. Methods- The Fushimi AF Registry is a community-based prospective survey of the patients with AF in Fushimi-ku, Kyoto. Analyses were performed on 4045 patients, which included 1974 paroxysmal AF (PAF; 48.8%) and 2071 sustained (persistent or permanent) AF (SAF; 51.2%) at baseline. Results- During the median follow-up period of 1105 days, progression of AF occurred in 252 patients with PAF (4.22 per 100 person-years). Multivariate Cox regression analysis demonstrated that progression of AF was significantly associated with an increased risk of ischemic stroke or systemic embolism (adjusted hazard ratio [HR], 4.10; 95% CI, 1.95-8.24; P<0.001 [versus PAF without progression]; adjusted HR, 2.20; 95% CI, 1.11-4.00; P=0.025 [versus SAF]) during progression period from paroxysmal to sustained forms. The risk after the progression was equivalent to SAF (adjusted HR, 1.54; 95% CI, 0.78-2.75; P=0.201 [versus SAF]). AF progression was significantly associated with a higher risk of hospitalization for heart failure (adjusted HR, 2.70; 95% CI, 1.55-4.52; P<0.001 [versus PAF without progression]; adjusted HR, 1.81; 95% CI, 1.08-2.88; P=0.026 [versus SAF]). Conclusions- Progression of AF was associated with increased risk of clinical adverse events during arrhythmia progression period from PAF to SAF among Japanese patients with AF. The risk of adverse events was transiently elevated during progression period from PAF to SAF and declined to the level equivalent to SAF after the progression. Clinical Trial Registration- URL: http://www.umin.ac.jp/ctr/ . Unique identifier: UMIN000005834.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ogawa H, An Y, Ikeda S, et al. Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events. Stroke. 2018. PMID: 30355097. doi:10.1161/STROKEAHA.118.021396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。